Vericel Corporation (VCEL) is a publicly traded Healthcare sector company. As of July 16, 2026, VCEL trades at $48.50 with a market cap of $2.35B and a P/E ratio of 141.83. VCEL moved +3.29% today. Year to date, VCEL is +29.74%; over the trailing twelve months it is +25.93%. Its 52-week range spans $28.95 to $63.00. Analyst consensus is strong buy with an average price target of $61.00. Rallies surfaces VCEL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for VCEL, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $48.50 |
| Market Cap | $2.35B |
| P/E Ratio | 141.83 |
| EPS | $0.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $63.00 |
| 52-Week Low | $28.95 |
| Volume | 64.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $276.26M |
| Net Income | $16.52M |
| Gross Margin | 74.42% |
4 analysts cover VCEL: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $61.00.